Amanote Research
Register
Sign In
Serum Hepatitis B Viral DNA in HBsAg-positive Hepatocellular Carcinoma Treated With Interferon or Adriamycin
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.1986.153
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 1, 1986
Authors
H J Lin
C L Lai
P C Wu
Publisher
Springer Science and Business Media LLC
Related search
Hepatocellular Carcinoma: High Hepatitis B Viral Load and Mortality in Patients Treated With Transarterial Chemoembolization
Radiology
Nuclear Medicine
Radiology
Imaging
Hepatitis B Virus DNA and E Antigen in Serum From Blood Donors Positive for HBsAg
BMJ
249ser TP53 Mutation in Plasma DNA, Hepatitis B Viral Infection, and Risk of Hepatocellular Carcinoma
Oncogene
Cancer Research
Genetics
Molecular Biology
Correlation of Hepatitis B Virus Viral Load and HBeAg Status in HBsAg Positive Patients
Asian Journal of Pharmacy and Pharmacology
Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals
Hepatology
Medicine
Hepatology
A Meta-Analysis and Systematic Review: Adjuvant Interferon Therapy for Patients With Viral Hepatitis-Related Hepatocellular Carcinoma
World Journal of Surgical Oncology
Surgery
Oncology
Histological Response Study of Chronic Viral Hepatitis C Patients Treated With Interferon Alone or Combined With Ribavirin
Brazilian Journal of Infectious Diseases
Infectious Diseases
Microbiology
Association of Serum Total Cholesterol With Pegylated Interferon-Α; Treatment in HBeAg-positive Chronic Hepatitis B Patients
Antiviral Therapy
Infectious Diseases
Pharmacology
Pretreatment Serum HBsAg-to-HBV DNA Ratio Predicts a Virologic Response to Entecavir in Chronic Hepatitis B
The Korean Journal of Hepatology
